SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001387131-22-000440
Filing Date
2022-01-19
Accepted
2022-01-18 17:32:25
Documents
1
Group Members
DAVID BONDERMANJAMES G. COULTERJON WINKELRIED

Document Format Files

Seq Description Document Type Size
1 AMENDED SC13D amneal_sc1da-011822.htm SC 13D/A 120858
  Complete submission text file 0001387131-22-000440.txt   122445
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Subject) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90473 | Film No.: 22536071
SIC: 2834 Pharmaceutical Preparations

Mailing Address 301 COMMERCE STREET SUITE 3300 FORT WORTH TX 76102
Business Address 301 COMMERCE STREET SUITE 3300 FORT WORTH TX 76102 (817) 871-4000
TPG GP A, LLC (Filed by) CIK: 0001903793 (see all company filings)

IRS No.: 872054646 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A